SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ:CYTX) (FWB:XMPA) will outline its commercialization strategy for the Celution™ System breast reconstruction product and provide an update on the start of the Celution™ System cardiovascular disease clinical trial Monday, February 12, at 11:35 AM Eastern Standard Time, from the 2nd Annual Stem Cell Summit.
